Browse > Article
http://dx.doi.org/10.5713/ajas.16.0207

Construction of Bacillus subtilis strain engineered for expression of porcine β-defensin-2/cecropin P1 fusion antimicrobial peptides and its growth-promoting effect and antimicrobial activity  

Xu, Jian (Department of Biotechnology, College of Environmental and Chemical Engineering, Yanshan University)
Zhong, Fei (Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Hebei Engineering and Technology Research Center of Veterinary Biotechnology)
Zhang, Yonghong (Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Hebei Engineering and Technology Research Center of Veterinary Biotechnology)
Zhang, Jianlou (Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Hebei Engineering and Technology Research Center of Veterinary Biotechnology)
Huo, Shanshan (Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Hebei Engineering and Technology Research Center of Veterinary Biotechnology)
Lin, Hongyu (Department of Biotechnology, College of Environmental and Chemical Engineering, Yanshan University)
Wang, Liyue (Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Hebei Engineering and Technology Research Center of Veterinary Biotechnology)
Cui, Dan (Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Hebei Engineering and Technology Research Center of Veterinary Biotechnology)
Li, Xiujin (Department of Biotechnology, College of Environmental and Chemical Engineering, Yanshan University)
Publication Information
Asian-Australasian Journal of Animal Sciences / v.30, no.4, 2017 , pp. 576-584 More about this Journal
Abstract
Objective: To generate recombinant Bacillus subtilis (B. subtilis) engineered for expression of porcine ${\beta}-defensin-2$ (pBD-2) and cecropin P1 (CP1) fusion antimicrobial peptide and investigate their anti-bacterial activity in vitro and their growth-promoting and disease resisting activity in vivo. Methods: The pBD-2 and CP1 fused gene was synthesized using the main codons of B. subtilis and inserted into plasmid pMK4 vector to construct their expression vector. The fusion peptide-expressing B. subtilis was constructed by transformation with the vector. The expressed fusion peptide was detected with Western blot. The antimicrobial activity of the expressed fusion peptide and the recovered pBD-2 and CP1 by enterokinase digestion in vitro was analyzed by the bacterial growth-inhibitory activity assay. To analyze the engineered B. subtilis on growth promotion and disease resistance, the weaned piglets were fed with basic diet supplemented with the recombinant B. subtilis. Then the piglets were challenged by enteropathogenic Escherichia coli (E. coli). The weight gain and diarrhea incidence of piglets were measured after challenge. Results: The recombinant B. subtilis engineered for expression of pBD-2/CP1 fusion peptide was successfully constructed using the main codons of the B. subtilis. Both expressed pBD-2/CP1 fusion peptide and their individual peptides recovered from parental fusion peptide by enterokinase digestion possessed the antimicrobial activities to a variety of the bacteria, including gram-negative bacteria (E. coli, Salmonella typhimurium, and Haemophilus parasuis) and grampositive bacteria (Staphylococcus aureus). Supplementing the engineered B. subtilis to the pig feed could significantly promote the piglet growth and reduced diarrhea incidence of the piglets. Conclusion: The generated B. subtilis strain can efficiently express pBD-2/CP1 fusion antimicrobial peptide, the recovered pBD-2 and CP1 peptides possess potent antimicrobial activities to a variety of bacterial species in vitro. Supplementation of the engineered B. subtilis in pig feed obviously promote piglet growth and resistance to the colibacillosis.
Keywords
Porcine ${\beta}-defensin-2$; Cecropin P1; Antimicrobial Activity; Engineered Bacillus subtilis; Piglets;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Han F, Zhang H, Xia X, et al. Porcine ${\beta}$-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. J Immunol 2015;194:1882-93.   DOI
2 Wei L, Zhong F, Xiu L, et al. Expression of Ascaris suum cecropin P1 gene in Pichia pastoris and its antimicrobial activity. Chin J Vet Sci 2011.
3 Arcidiacono S, Soares JW, Meehan A, Marek P, Kirby R. Membrane permeability and antimicrobial kinetics of cecropin P1 against Escherichia coli. J Pept Sci 2009;15:398-403.   DOI
4 Gregory K, Mello CM. Immobilization of Escherichia coli cells by use of the antimicrobial peptide cecropin P1. Appl Environ Microbiol 2005;71:1130-4.   DOI
5 Mukherjee S, Hooper LV. Antimicrobial defense of the intestine. Immunity 2015;42:28-39.   DOI
6 Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med 2013;5:1465-83.   DOI
7 Spizizen J. Transformation of biochemically deficient strains of Bacillus subtilis by deoxyribonuclease. Proc Natl Acad Sci USA 1958;44:1072-8.   DOI
8 Wang X, Li X, Zhang Z, Shen X, Zhong F. Codon optimization enhances secretory expression of Pseudomonas aeruginosa exotoxin A in E. coli. Protein Expr Purif 2010;72:101-6.   DOI
9 Yang W, Feng J, Xiang F, et al. Endogenous animal toxin-like human ${\beta}$-defensin 2 inhibits own K+ channels through interaction with channel extracellular pore region. Cell Mol Life Sci 2014;72:845-53.
10 Harwig SS, Eisenhauer PB, Chen NP, Lehrer RI. Cryptdins: endogenous antibiotic peptides of small intestinal paneth cells. Adv Exp Med Biol 1995:251-5.
11 Vargues T, Morrison G, Seo ES, et al. Efficient production of human ${\beta}$-Defensin 2 (HBD2) in Escherichia coli. Protein Pept Lett 2009;16:668-76.   DOI
12 Wu S, Zhang F, Huang Z, et al. Effects of the antimicrobial peptide cecropin AD on performance and intestinal health in weaned piglets challenged with Escherichia coli. Peptides 2012;35:225-30.   DOI
13 Li C, Zhao Y, Song X, Huang X, Zhao W. Molecular cloning, expression and characterization of the porcine beta defensin 2 in E. coli. Protein Pept Lett 2013;20:715-23.   DOI
14 Bonavita R, Isticato R, Maurano F, Ricca E, Rossi M. Mucosal immunity induced by gliadin-presenting spores of Bacillus subtilis in HLA-DQ8-transgenic mice. Immunol Lett 2015;165:84-9.   DOI
15 Zokaeifar H, Balcazar JL, Saad CR, et al. Effects of Bacillus subtilis on the growth performance, digestive enzymes, immune gene expression and disease resistance of white shrimp, Litopenaeus vannamei. Fish Shellfish Immunol 2012;33:683-9.   DOI
16 Sorokulova I, Pinchuk IV, Denayrolles M, et al. The safety of two bacillus probiotic strains for human use. Dig Dis Sci 2008;53:954-63.   DOI
17 Saida F, Uzan M, Odaert B, Bontems F. Expression of highly toxic genes in E. coli: special strategies and genetic tools. Curr Protein Pept Sci 2006;7:47-56.   DOI
18 Tatsuda D, Arimura H, Tokunaga H, et al. Expression and purification of cytokine receptor homology domain of human granulocyte-colony-stimulating factor receptor fusion protein in Escherichia coli. Protein Expr Purif 2001;21:87-91.   DOI
19 Cheng G, Hao H, Xie S, et al. Antibiotic alternatives: the substitution of antibiotics in animal husbandry? Front Microbiol 2014;5:217.
20 Jukes TH. Antibiotics in meat production. JAMA 1975;232:292-3.   DOI
21 Stanton TB. A call for antibiotic alternatives research. Trends Microbiol 2013;21:111-3.   DOI
22 Marshall B, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev 2011;24:718-33.   DOI
23 Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. Recurrent Septicemia in an Immunocompromised Patient Due to Probiotic Strains of Bacillus subtilis. J Clin Microbiol 1998;36:325-6.
24 Castanon JI. History of the use of antibiotic as growth promoters in european poultry feeds. Poult Sci 2007;86:2466-71.   DOI
25 Wang N, Guo X, Xu J, et al. Pollution characteristics and environmental risk assessment of typical veterinary antibiotics in livestock farms in Southeastern China. J Environ Sci Health B 2014;49:468-79.   DOI
26 Collins MD, Gibson GR. Probiotics, prebiotics and symbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:1052-7.   DOI
27 Baker AA, Davis E, Spencer JD, Moser R, Rehberger T. The effect of a -based direct-fed microbial supplemented to sows on the gastrointestinal microbiota of their neonatal piglets. J Anim Sci 2013;91:3390-9.   DOI
28 Sang Y, Blecha F. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. Anim Health Res Rev 2008;9:227-35.   DOI
29 Fellermann K, Stange EF. Defensinsinnate-immunity at the epithelial frontier. Eur J Gastroenterol Hepatol 2001;13:771-6.   DOI